Vorderstrasse Beth A, Dearstyne Erica A, Kerkvliet Nancy I
Department of Environmental and Molecular Toxicology and Environmental Health Sciences Center, Oregon State University, Corvallis, Oregon 97331, USA.
Toxicol Sci. 2003 Mar;72(1):103-12. doi: 10.1093/toxsci/kfg012.
We have previously shown that exposure of mice to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) induces activation-like changes in splenic dendritic cells (DC) in the absence of antigen challenge. Since activation of DC reduces their ability to phagocytize antigen, we examined the effects of TCDD on the ability of DC to process and present antigen to antigen-specific T cells and to internalize latex beads. Additionally, the expression of costimulatory and adhesion molecules was examined on DC from TCDD-treated mice injected with allogeneic tumor cells. The ability of DC from C57Bl/6 mice to induce proliferation of keyhole limpet hemocyanin (KLH)-specific 10.5.17 T cells and production of IL-4 was not significantly altered by TCDD exposure, either when KLH was added in vitro or when the mice were injected with KLH prior to DC isolation. In contrast, ovalbumin (OVA) presentation by DC from TCDD-treated Balb/c mice induced enhanced proliferation of OVA-specific D011.10 T cells, although the production of IL-2 and IFN-gamma was not affected. Enhanced in vivo proliferation of adoptively transferred, CFSE-labeled DO11.10 T cells was also observed in TCDD-treated Balb/c mice that were challenged with OVA. TCDD treatment modulated the expression of major histocompatibility complex (MHC) class II, CD24, ICAM-1, CD40, and LFA-1 on splenic DC from C57Bl/6 mice injected with allogeneic tumor cells; however, the effects of TCDD were identical to changes seen previously in nonimmune mice, suggesting that these effects were not antigen-dependent. Finally, TCDD treatment did not affect the ability of splenic DC to internalize latex beads administered in vivo. Taken together, these results suggest that the activation-like changes induced in DC by TCDD do not suppress the ability of DC to process and present antigen, but may enhance their ability to provide activation signals to T cells. This, in turn, may alter the survival of the T cells, the DC, or both, and might lead to dysregulation of the immune response.
我们之前已经表明,在没有抗原刺激的情况下,将小鼠暴露于2,3,7,8-四氯二苯并对二恶英(TCDD)会诱导脾树突状细胞(DC)出现激活样变化。由于DC的激活会降低其吞噬抗原的能力,我们研究了TCDD对DC处理和呈递抗原给抗原特异性T细胞以及内化乳胶珠能力的影响。此外,还检测了注射同种异体肿瘤细胞的TCDD处理小鼠的DC上共刺激分子和黏附分子的表达。当在体外添加血蓝蛋白(KLH)时,或者在分离DC之前给小鼠注射KLH时,TCDD暴露均未显著改变C57Bl/6小鼠的DC诱导KLH特异性10.5.17 T细胞增殖和产生白细胞介素-4(IL-4)的能力。相比之下,TCDD处理的Balb/c小鼠的DC呈递卵清蛋白(OVA)可诱导OVA特异性D011.10 T细胞增殖增强,尽管白细胞介素-2(IL-2)和干扰素-γ(IFN-γ)的产生未受影响。在用OVA攻击的TCDD处理的Balb/c小鼠中,还观察到过继转移的、羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)标记的D011.10 T细胞在体内增殖增强。TCDD处理调节了注射同种异体肿瘤细胞的C57Bl/6小鼠脾DC上主要组织相容性复合体(MHC)II类、CD24、细胞间黏附分子-1(ICAM-1)、CD40和淋巴细胞功能相关抗原-1(LFA-1)的表达;然而,TCDD的作用与之前在非免疫小鼠中观察到的变化相同,这表明这些作用不依赖于抗原。最后,TCDD处理不影响脾DC内化体内给予的乳胶珠的能力。综上所述,这些结果表明,TCDD在DC中诱导的激活样变化不会抑制DC处理和呈递抗原的能力,但可能增强其向T细胞提供激活信号的能力。反过来,这可能会改变T细胞、DC或两者的存活,并可能导致免疫反应失调。